Summary
Numerous trials have demonstrated the negative effects of some antihypertensive drugs upon glucose handling. Such findings seem particularly interesting in aged hypertensive patients who are also insulin resistant and affected by physiological changes in the renal and cardiovascular systems.
It appears that calcium channel blockers and angiotensin converting enzyme (ACE) inhibitors are the most appropriate drugs to lower blood pressure in aged insulin-resistant hypertensive patients. All calcium channel blockers studied have displayed similar metabolic effects, while among the ACE inhibitors studied, lisinopril was associated with the best metabolic responses. β-Blockers and thiazide diuretics have strong negative effects on glucose handling.
Further studies are needed in order to investigate the metabolic effects of α1-antagonists in aged patients with insulin resistance and hypertension.
Similar content being viewed by others
References
Amery A, Brixco P, Clement DL, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1: 1349–1354, 1985
Beretta-Piccoli C, Davies DL, Boddy K, et al. Relation of arterial blood pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clinical Science 63: 257–260, 1982
Block HR. Therapeutic considerations in the elderly hypertensives: the role of calcium channel blockers. American Journal of Hypertension 3: 347S–354S, 1990
Bühler FR, Multhen UL, Kiowski W, et al. Greater antihypertensive efficacy of the calcium channel inhibitor verapamil in older and low renin patients. Clinical Science 63(Suppl. 2): 439S–442S, 1982
Bühler FR, Kiowski W. Age and antihypertensive response to calcium antagonist. Journal of Hypertension 5(Suppl. 4): 111S–114S, 1987
Clansen T, Elrink J, Morten BR. Insulin controlling calcium distribution in muscle and fat cells. Acta Endocrinologica 77: 137–143, 1974
Dietze GJ. Modulation of the action of insulin in relation to the energy state in skeletal muscle. Possible involvement of kinins and prostaglandins. Molecular and Cellular Endocrinology 25: 127–149, 1982
Draznin B, Kao M, Sussman KE. Insulin and glyburide increase free calcium concentration in isolated rat adipocytes. Diabetes 36: 174–178 1987
Draznin B, Sussman KE, Eckel RH, et al. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hypertension. Journal of Clinical Investigation 82: 1848–1852, 1988
Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. New England Journal of Medicine 317: 350–357, 1987
Ferrari P, Giachino D, Weidman L, et al. Unalterated insulin sensitivity during calcium channel blockade with amlodipine. European Journal of Clinical Pharmacology 41: 109–113, 1991
Ferrari P, Weidmann P. Insulin, insulin sensitivity and hypertension. Journal of Hypertension 8: 491–500, 1990
Fink RI, Kolterman OG, Griffin J, et al. Mechanism of insulin resistance in aging. Journal of Clinical Investigation 71: 1523–1529, 1983
Giugliano D, Saccomanno F, Paolisso G, et al. Nicardipine does not cause deterioration of glucose homeostasis in man: a placebo controlled study in elderly hypertensive with and without diabetes mellitus. European Journal of Clinical Pharmacology 43: 39–45, 1992
Hully SB, Furberg CK, Gurland B, et al. Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. American Journal of Cardiology 56: 913–920, 1985
Jackson RA. Mechanisms of age-related glucose intolerance. Diabetes Care 13(Suppl. 2): 9–19, 1990
Jauch KW, Guenther B, Hartl W, et al. Improvement of impaired post-operative insulin action by bradykinin. Biological Chemistry Hoppe-Seyler 367: 207–210, 1986
Klip A. Is intracellular Ca involved in insulin stimulation of sugar transport? Fact and prejudice. Canadian Journal of Biochemistry 62: 1228–1236, 1984
Kodama J, Katayama S, Tanaka K, et al. Effect of captopril on glucose concentration. Possible role of augmented post- prandial forearm blood flow. Diabetes Care 13: 1109–1111, 1990
Laasko M, Edelman V, Brechtel G, et al. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese men. A novel mechanism for insulin resistance. Journal of Clinical Investigation 85: 1844–1852, 1990
Levy D, Garrison RJ, Savage D, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New England Journal of Medicine 322: 1561–1566, 1990
Levy D, Garrison RJ, Savage D, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Annals of Internal Medicine 110: 101–107, 1989
Lillioja S, Young AA, Culter CL, et al. Skeletal muscle capillary density and fiber type are possible determinations of in vivo insulin resistance in men. Journal of Clinical Investigation 80: 1620–1628, 1987
Lithell HOL. Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 14: 203–209, 1991
Morris AD, Donnely R, Connell JM, et al. Metabolic effects of lacidipine: a placebo-controlled study using the euglycemic hyperinsulinemic glucose clamp. British Journal of Clinical Pharmacology 35: 40–45, 1993
Paolisso G, Di Maro G, Cozzolino D, et al. Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients. American Journal of Hypertension 5: 681–686, 1992
Paolisso G, Gambardella A, Balbi V, et al. Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation and blood pressure in aged hypertensive patients. American Journal of Hypertension 6: 920–926, 1993
Paolisso G, Gambardella A, Verza M, et al. ACE-inhibition improves insulin sensitivity in aged insulin-resistant hypertensive patients. Journal of Human Hypertension 6: 175–179, 1992
Paolisso G, Marrazzo G, Pizza G, et al. Insulin resistance as a cause of increased blood pressure in the elderly: effects on intracellular ions content. Archives of Gerontology and Geriatrics 11: 23–32, 1990a
Paolisso G, Scheen AS, D’Onofrio F, Lefebvre PJ. Magnesium and glucose homeostasis. Diabetologia 313: 511–514, 1990b
Paolisso G, Sgambato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12: 265–269, 1989
Pollare T, Lithell H, Berne C. A comparisons of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. New England Journal of Medicine 321: 868–873, 1989a
Pollare T, Lithell H, Mörlin C, et al. Metabolic effects of diltiazem and atenolol: results from a randomized double-blind study with parallel groups. Journal of Hypertension 7: 551–559, 1989b
Pollare T, Lithell H, Selinus I, et al. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31: 415–420, 1988
Pollare T, Lithell H, Selinus I, et al. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double-blind study of the effects on carbohydrate and lipo- protein metabolism in patients with hypertension. British Medical Journal 297: 1147–1152, 1989
Resnick L. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. American Journal of Medicine 93(Suppl. 2A): 11S–20S, 1992
Santoro D, Natali A, Palombo C, et al. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension. Hypertension 20: 181–191, 1992
Varricchio M, Paolisso B, Torella R, D’Ouofrio F. Diabetes and hypertension in the elderly. Journal of hypertension 67(Suppl. 1): 910–915, 1988
Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for initial treatment of hypertension. Journal of the American Medical Association 248: 1996–2003, 1982
Vidt DG, Borazanian RA. Calcium channel blockers in geriatric hypertension. Geriatrics 41: 28–38, 1991
Williams GH. Converting-enzyme inhibitors in the treatment of hypertension. New England Journal of Medicine 319: 1517–1521, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paolisso, G., Gambardella, A., Galzerano, D. et al. Insulin Resistance and Hypertension in the Elderly. Drugs & Aging 4, 403–409 (1994). https://doi.org/10.2165/00002512-199404050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199404050-00005